Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol as Maintenance Therapy in Autoimmune Hepatitis
NCT04129489Phase 2Terminated
- Sponsor
- STERO Biotechs
- Start
- Feb 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in autoimmune hepatitis (AIH), sponsored by STERO Biotechs. Started Feb 2019; status: terminated.
02
Drugs
cannabidiol
03
Conditions
autoimmune hepatitis (AIH)
Beyond the preview
Go deeper on NCT04129489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04129489.